Quick Answer
Coya Therapeutics, Inc. reported Total Assets of $49.95 million for the year ending 2025.
- Coya Therapeutics, Inc. showed an increase of +12.6% in Total Assets from 2024 to 2025.
- This data is from Coya Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $17.42 million | Q2 2023: $14.47 million | Q3 2023: $11.90 million | Q1 2024: $37.39 million | Q2 2024: $39.94 million | Q3 2024: $35.55 million | Q1 2025: $38.40 million | Q2 2025: $33.45 million | Q3 2025: $32.04 million.
- Over the full 5 years of available data (2021 to 2025), Coya Therapeutics, Inc.'s Total Assets has grown by 942.3%.
- Historical annual values: Fiscal year 2025: $49.95 million | Fiscal year 2024: $44.35 million | Fiscal year 2023: $41.26 million | Fiscal year 2022: $8.40 million | Fiscal year 2021: $4.79 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: